196 related articles for article (PubMed ID: 31240551)
1. Improving medication safety in oncology care: impact of clinical pharmacy interventions on optimizing patient safety.
Patel H; Gurumurthy P
Int J Clin Pharm; 2019 Aug; 41(4):981-992. PubMed ID: 31240551
[TBL] [Abstract][Full Text] [Related]
2. The ten most common adverse drug reactions (ADRs) in oncology patients: do they matter to you?
Lau PM; Stewart K; Dooley M
Support Care Cancer; 2004 Sep; 12(9):626-33. PubMed ID: 15064936
[TBL] [Abstract][Full Text] [Related]
3. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
Jose J; Rao PG
Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
[TBL] [Abstract][Full Text] [Related]
4. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
[TBL] [Abstract][Full Text] [Related]
5. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
Geer MI; Koul PA; Tanki SA; Shah MY
J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
[TBL] [Abstract][Full Text] [Related]
6. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
[TBL] [Abstract][Full Text] [Related]
7. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department.
Olivier P; Boulbés O; Tubery M; Lauque D; Montastruc JL; Lapeyre-Mestre M
Drug Saf; 2002; 25(14):1035-44. PubMed ID: 12408734
[TBL] [Abstract][Full Text] [Related]
8. A prospective analysis of the preventability of adverse drug reactions reported in Sweden.
Lövborg H; Eriksson LR; Jönsson AK; Bradley T; Hägg S
Eur J Clin Pharmacol; 2012 Aug; 68(8):1183-9. PubMed ID: 22349466
[TBL] [Abstract][Full Text] [Related]
9. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
10. Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands.
Dequito AB; Mol PG; van Doormaal JE; Zaal RJ; van den Bemt PM; Haaijer-Ruskamp FM; Kosterink JG
Drug Saf; 2011 Nov; 34(11):1089-100. PubMed ID: 21981436
[TBL] [Abstract][Full Text] [Related]
11. Development of a 'ready-to-use' tool that includes preventability, for the assessment of adverse drug events in oncology.
Hébert G; Netzer F; Kouakou SL; Lemare F; Minvielle E;
Int J Clin Pharm; 2018 Apr; 40(2):376-385. PubMed ID: 29446003
[TBL] [Abstract][Full Text] [Related]
12. Frequency and preventability of adverse drug reactions in paediatric patients.
Temple ME; Robinson RF; Miller JC; Hayes JR; Nahata MC
Drug Saf; 2004; 27(11):819-29. PubMed ID: 15350153
[TBL] [Abstract][Full Text] [Related]
13. Adverse drug reactions in a pulmonary teaching hospital: incidence, pattern, seriousness, and preventability.
Baniasadi S; Fahimi F
Curr Drug Saf; 2011 Sep; 6(4):230-6. PubMed ID: 22129318
[TBL] [Abstract][Full Text] [Related]
14. Adverse drug reactions experience in a teaching hospital in Jordan.
Alsbou M; Alzubiedi S; Alzobi H; Samhadanah NA; Alsaraireh Y; Alrawashdeh O; Aqel A; Al-Salem K
Int J Clin Pharm; 2015 Dec; 37(6):1188-93. PubMed ID: 26286340
[TBL] [Abstract][Full Text] [Related]
15. Adverse drug reaction monitoring in a secondary care hospital in South India.
Arulmani R; Rajendran SD; Suresh B
Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
[TBL] [Abstract][Full Text] [Related]
16. Comparison of adverse drug reactions detected by pharmacy and medical records departments.
Johnstone DM; Kirking DM; Vinson BE
Am J Health Syst Pharm; 1995 Feb; 52(3):297-301. PubMed ID: 7749958
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study comparing interventions by oncology and non-oncology pharmacists in outpatient chemotherapy.
Kaya M; Nakamura K; Nagamine M; Suyama Y; Nakajo M; Uchida R; Hagikura K; Kanda A; Sugiyama K; Sugiyama R; Nakagaki S; Kimura M
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1371. PubMed ID: 33739629
[TBL] [Abstract][Full Text] [Related]
19. Adverse Drug Reaction Profile of Anticancer Agents in a Tertiary Care Hospital: An Observational Study.
Shaikh SP; Nerurkar R
Curr Drug Saf; 2022; 17(2):136-142. PubMed ID: 34433404
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug reaction profile of microtubule-damaging antineoplastic drugs: A focused pharmacovigilance study in India.
Manohar HD; Adiga S; Thomas J; Sharma A
Indian J Pharmacol; 2016; 48(5):509-514. PubMed ID: 27721535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
